| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +7.0% |
| 3Y CAGR | -6% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +45% |
| 3Y CAGR | +7.0% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,419.50 +43.40 (1.83%) | 18,042.14 | 26.61 | 5.35 | ||
PfizerPFIZER | ₹3,772.70 +12.90 (0.34%) | 17,202.98 | 23.4 | 4.09 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,265.00 -34.00 (0.54%) | 15,745.13 | 92.82 | 18.04 | ||
Natco PharmaNATCOPHARM | ₹800.30 +12.75 (1.62%) | 15,453.13 | 13.5 | 1.47 |